跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ZOLEDRONIC ACID FRESENIUS KABI CONCENTRATE FOR SOLUTION FOR INFUSION 4MG/5ML - HSA Drug Approval Details
Approvals
/
HSA
/
ZOLEDRONIC ACID FRESENIUS KABI CONCENTRATE FOR SOLUTION FOR INFUSION 4MG/5ML
Approved
THERAPEUTIC
ZOLEDRONIC ACID FRESENIUS KABI CONCENTRATE FOR SOLUTION FOR INFUSION 4MG/5ML
Fresenius Kabi Austria GmbH (Plant Graz)
🇸🇬 Health Sciences Authority
Approval Date
Feb 1, 2016
Approval ID
c08babc58451cdce
Company
Fresenius Kabi Austria GmbH (Plant Graz)
Type
Therapeutic
Approval Details
Approval Id
c08babc58451cdce
Drug Name
ZOLEDRONIC ACID FRESENIUS KABI CONCENTRATE FOR SOLUTION FOR INFUSION 4MG/5ML
Product Name
ZOLEDRONIC ACID FRESENIUS KABI CONCENTRATE FOR SOLUTION FOR INFUSION 4MG/5ML
Approval Number
SIN14934P
Approval Date
2016-02-01
Registrant
FRESENIUS KABI (SINGAPORE) PTE LTD
Licence Holder
FRESENIUS KABI (SINGAPORE) PTE LTD
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INFUSION, SOLUTION CONCENTRATE
Route Of Administration
INTRAVENOUS
Atc Code
M05BA08
Atc Item Name
zoledronic acid
Pharma Manufacturer Name
FRESENIUS KABI (SINGAPORE) PTE LTD
Company Detail Path
/organization/fresenius-kabi-singapore-pte-ltd
Active Ingredients
Zoledronic acid monohydrate 4.264mg/5ml eqv Zoledronic acid anhydrous
4mg/5ml
ZOLEDRONIC ACID MONOHYDRATE 4.264 MG/5 ML EQV ZOLEDRONIC ACID ANHYDROUS
4 MG/5 ML
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Feb 1, 2016
Approval ID
c08babc58451cdce
Type
Therapeutic
Back to HSA Approvals